Abstract Objective To evaluate the risk factors for postpartum hemorrhage (PPH) according to the Robson Classification in a low-risk maternity hospital. Methods We conducted retrospective cohort study by analyzing the medical records of pregnant women attended in a low-risk maternity hospital, during from November 2019 to November 2021. Variables analyzed were: maternal age, type of delivery, birth weight, parity, Robson Classification, and causes of PPH. We compared the occurrence of PPH between pregnant women with spontaneous (Groups 1 and 3) and with induction of labor (2a and 4a). Chi-square and Student t-tests were performed. Variables were compared using binary logistic regression. Results There were 11,935 deliveries during the study period. According to Robson’s Classification, 48.2% were classified as 1 and 3 (Group I: 5,750/11,935) and 26.1% as 2a and 4a (Group II: 3,124/11,935). Group II had higher prevalence of PPH than Group I (3.5 vs. 2.7%, p=0.028). Labor induction increased the occurrence of PPH by 18.8% (RR: 1.188, 95% CI: 1.02-1.36, p=0.030). Model including forceps delivery [x2(3)=10.6, OR: 7.26, 95%CI: 3.32-15.84, R2 Nagelkerke: 0.011, p<0.001] and birth weight [x2(4)=59.0, OR: 1.001, 95%CI:1.001-1.001, R2 Nagelkerke: 0.033, p<0.001] was the best for predicting PPH in patients classified as Robson 1, 3, 2a, and 4a. Birth weight was poor predictor of PPH (area under ROC curve: 0.612, p<0.001, 95%CI: 0.572-0.653). Conclusion Robson Classification 2a and 4a showed the highest rates of postpartum hemorrhage. The model including forceps delivery and birth weight was the best predictor for postpartum hemorrhage in Robson Classification 1, 3, 2a, and 4a. (PPH lowrisk low hospital 201 2021 age parity Groups . 4a) Chisquare Chi square ttests t tests performed regression 11935 11 935 11,93 period Robsons s 482 48 2 48.2 5,750/11,935 575011935 5 750 261 26 26.1 3,124/11,935. 312411935 3,124/11,935 124 3,124/11,935) 3.5 35 (3. vs 27 7 2.7% p=0.028. p0028 p p=0.028 0 028 p=0.028) 188 18 8 18.8 RR (RR 1188 1.188 95 CI 1.021.36, 102136 1.02 1.36, 02 36 1.02-1.36 p=0.030. p0030 p=0.030 030 p=0.030) x23=10.6, x23106 x x2 =10.6, 10 6 [x2(3)=10.6 OR 726 7.26 95%CI 95CI 3.3215.84, 3321584 3.32 15.84, 32 15 84 3.32-15.84 R Nagelkerke 0011 011 0.011 p<0.001 p0001 001 x24=59.0, x24590 4 =59.0, 59 [x2(4)=59.0 1001 1.001 95%CI1.0011.001, 95CI10011001 95%CI:1.001-1.001 0033 033 0.033 area curve 0612 612 0.612 0.5720.653. 05720653 0.572 0.653 572 653 0.572-0.653) 20 202 1193 93 11,9 48. 5,750/11,93 57501193 75 26. 31241193 3,124/11,93 12 3. (3 2.7 p002 p=0.02 18. 118 1.18 9 021 1.021.36 10213 102 1.0 136 1.36 1.02-1.3 p003 p=0.03 03 x23 x23=10.6 x2310 106 =10.6 [x2(3)=10. 72 7.2 3215 3.3215.84 332158 332 3.3 1584 15.84 3.32-15.8 01 0.01 p<0.00 p000 00 x24 x24=59.0 x2459 590 =59.0 [x2(4)=59. 100 1.00 CI1 95%CI1.0011.001 95CI1001100 95%CI:1.001-1.00 003 0.03 061 61 0.61 5720 0.5720.653 0572065 0572 0.57 0653 0.65 57 65 0.572-0.653 119 11, 5,750/11,9 5750119 3124119 3,124/11,9 ( 2. p00 p=0.0 1.1 1.021.3 1021 1. 13 1.3 1.02-1. x23=10. x231 =10. [x2(3)=10 7. 321 3.3215.8 33215 33 158 15.8 3.32-15. 0.0 p<0.0 x24=59. x245 =59. [x2(4)=59 95%CI1.0011.00 95CI100110 95%CI:1.001-1.0 06 0.6 0.5720.65 057206 057 0.5 065 0.572-0.65 5,750/11, 575011 312411 3,124/11, p0 p=0. 1.021. 1.02-1 x23=10 =10 [x2(3)=1 3.3215. 3321 15. 3.32-15 0. p<0. x24=59 =59 [x2(4)=5 95%CI1.0011.0 95CI10011 95%CI:1.001-1. 0.5720.6 05720 05 0.572-0.6 5,750/11 57501 31241 3,124/11 p=0 1.021 1.02- x23=1 =1 [x2(3)= 3.3215 3.32-1 p<0 x24=5 =5 [x2(4)= 95%CI1.0011. 95CI1001 95%CI:1.001-1 0.5720. 0.572-0. 5,750/1 5750 3124 3,124/1 p= x23= = [x2(3) 3.321 3.32- p< x24= [x2(4) 95%CI1.0011 95CI100 95%CI:1.001- 0.5720 0.572-0 5,750/ 575 312 3,124/ [x2(3 [x2(4 95%CI1.001 95CI10 95%CI:1.001 0.572- 5,750 31 3,124 [x2( 95%CI1.00 95CI1 95%CI:1.00 5,75 3,12 [x2 95%CI1.0 95%CI:1.0 5,7 3,1 [x 95%CI1. 95%CI:1. 5, 95%CI1 95%CI:1

SUMMARY OBJECTIVE: The aim of this study was to evaluate the impact of therapeutic hypothermia on maternal and perinatal outcomes in newborns with Apgar score<7 at the 5th min. METHODS: A retrospective cohort study was carried out with 55 newborns who had an Apgar score<7 at the 5th min (35 without and 20 with therapeutic hypothermia) from low-risk pregnancies between 33 and 41 weeks gestation. The Apgar score was calculated through an objective assessment by a neonatologist in the delivery room. Therapeutic hypothermia was indicated by a neonatologist in the delivery room, according to the protocol established by the Brazilian Society of Pediatrics. The maternal and perinatal outcomes of both groups (without and with therapeutic hypothermia) were compared. RESULTS: A rate of Apgar score<7 at the 5th min was 1.02%. No statistical differences were observed between the two groups (without and with therapeutic hypothermia) regarding maternal/perinatal complications. The presence of maternal/perinatal complications did not increase the odds ratio of neonatal therapeutic hypothermia in newborns with Apgar score<7 at the 5th min. CONCLUSION: The rate of Apgar score<7 at the 5th min was low, and it was not associated with any maternal/perinatal complications. There was no significant difference in maternal/perinatal complications between newborns who received therapeutic hypothermia and those who did not. OBJECTIVE score7 7 score< th METHODS 5 35 (3 2 lowrisk low risk 3 4 gestation room Pediatrics compared RESULTS 102 1 02 1.02% maternalperinatal CONCLUSION ( 10 0 1.02 1.0 1.

SUMMARY OBJECTIVE: The aim of this study was to evaluate the serum hCG level in the differential diagnosis between non-molar miscarriage and complete hydatidiform mole in<11 weeks gestation. METHODS: This was a retrospective collaborative cohort study. This study included women with gestational age<11 weeks, with ultrasound evidence of failed pregnancy and available serum hCG pre-uterine evacuation, divided into two groups: the non-molar miscarriage group and the complete hydatidiform mole group. Serum hCG levels were compared according to gestational age. Statistical analysis used a nonparametric test with a 5% significance level (p<0.05). RESULTS: In total, 416 patients were included, out of which 79 were included in the non-molar miscarriage group and 337 in the complete hydatidiform mole group. The calculated power of the sample was more than 80%. Data analysis showed that the 75th quartile of the median in the non-molar miscarriage group was always lower than the 25th quartile of the median in the complete hydatidiform mole group [9,721 mUI/mL/16,435 mUI/mL (6–7 weeks), 20,229 mUI/mL/64,911 mUI/mL (8–9 weeks), and 29,633 mUI/mL/126,278 mUI/mL (10–11 weeks), respectively; p<0.001]. CONCLUSION: Facing failed pregnancies, hCG>16,435 mUI/mL at 6–7 weeks, hCG>64,911 mUI/mL at 8–9 weeks, and hCG >126,278 mUI/mL at 10–11 weeks were most prevalent on complete hydatidiform mole diagnosis. On the contrary, hCG<30,000 mUI/mL at 10–11 weeks was most prevalent in non-molar miscarriage diagnosis. OBJECTIVE nonmolar non molar in11 11 in<1 gestation METHODS age11 age age<1 preuterine pre uterine evacuation groups 5 p<0.05. p005 p p<0.05 . 0 05 (p<0.05) RESULTS total 41 7 33 80 80% th 9,721 9721 9 721 [9,72 mUImL16435 mUImL mUI mL 16 435 mUI/mL/16,43 67 6 (6– , weeks) 20229 20 229 20,22 mUImL64911 64 911 mUI/mL/64,91 89 8 (8– 29633 29 633 29,63 mUImL126278 126 278 mUI/mL/126,27 1011 10 (10–1 respectively p<0.001. p0001 p<0.001 001 p<0.001] CONCLUSION pregnancies hCG16435 hCG>16,43 6– hCG64911 hCG>64,91 8– 126278 >126,27 10–1 contrary hCG30000 30 000 hCG<30,00 in1 1 in< age1 age< p00 p<0.0 (p<0.05 4 3 9,72 972 72 [9,7 mUImL1643 43 mUI/mL/16,4 (6 2022 2 22 20,2 mUImL6491 91 mUI/mL/64,9 (8 2963 63 29,6 mUImL12627 12 27 mUI/mL/126,2 101 (10– p000 p<0.00 00 hCG1643 hCG>16,4 hCG6491 hCG>64,9 12627 >126,2 10– hCG3000 hCG<30,0 p0 p<0. (p<0.0 9,7 97 [9, mUImL164 mUI/mL/16, ( 202 20, mUImL649 mUI/mL/64, 296 29, mUImL1262 mUI/mL/126, (10 hCG164 hCG>16, hCG649 hCG>64, 1262 >126, hCG300 hCG<30, p<0 (p<0. 9, [9 mUImL16 mUI/mL/16 mUImL64 mUI/mL/64 mUImL126 mUI/mL/126 (1 hCG16 hCG>16 hCG64 hCG>64 >126 hCG30 hCG<30 p< (p<0 [ mUImL1 mUI/mL/1 mUImL6 mUI/mL/6 mUImL12 mUI/mL/12 hCG1 hCG>1 hCG6 hCG>6 >12 hCG3 hCG<3 (p< mUI/mL/ hCG> >1 hCG< (p >

Resumo Objetivo Lúpus eritematoso sistêmico (LES) pode causar danos irreversíveis aos órgãos. A gravidez com LES pode ter riscos para condições ameaçadoras à vida. O presente estudo teve como objetivo determinar a prevalência de MMG em pacientes com LES e analisar os parâmetros que contribuíram para os casos de maior gravidade. Métodos Trata-se de um estudo transversal retrospectivo a partir da análise de dados obtidos de prontuários de gestantes com LES atendidas em um Hospital Universitário no Brasil. As gestantes foram divididas em grupo controle sem intercorrências, grupo com condições potencialmente ameaçadoras a vida (CPAV) e grupo com near miss materno (NMM). Resultados A taxa de NMM foi de 112,9 por 1.000 nascidos vivos. A maioria dos casos de CPAV (83,9%) e NMM (92,9%) teve partos prematuros com risco aumentado estatisticamente significativo em comparação com o grupo controle (p = 0,0042; odds ratio [OR]: 12,05; intervalo de confiança [IC]: 1,5–96,6 para o grupo NMM e p = 0,0001; OR: 4,84; IC95%: 2,2–10,8 para o grupo CPAV). MMG aumenta o risco de maior tempo de internação (p < 0,0001; OR: 18,8; IC95%: 7,0–50,6 e p < 0,0001; OR: 158,17; IC95%: 17,6–1424,2 para os grupos CPAV e NMM, respectivamente), recémnascidos com baixo peso (p = 0,0006; OR: 3,67; IC95%: 1,7–7,9 e p = 0,0009; OR: 17,68; IC95%: 2–153,6 para os grupos CPAV e NMM, respectivamente), bem como doenças renais (CPAV: 58,9%; 33/56; p = 0,0069 e NMM: 78,6%; 11/14; p = 0,0026)]. Os casos de NMM apresentaram risco aumentado para óbito neonatal (p = 0,0128; OR: 38,4; IC95%: 3,3–440,3), natimorto e aborto espontâneo (p = 0,0011; OR: 7,68; IC95%: 2,2–26,3). Conclusão Lúpus eritematoso sistêmico foi significativamente associado à morbidade materna grave, internações mais longas e risco aumentado de desfechos obstétricos e neonatais ruins. (LES órgãos gravidade Tratase Trata se Brasil intercorrências (CPAV NMM. . (NMM) 1129 112 9 112, 1000 1 000 1.00 vivos 83,9% 839 83 (83,9% 92,9% 929 92 (92,9% 0,0042 00042 0 0042 OR [OR] 12,05 1205 12 05 IC [IC] 15966 5 96 6 1,5–96, 0,0001 00001 0001 4,84 484 4 84 IC95% IC95 22108 2 10 8 2,2–10, CPAV. CPAV) 18,8 188 18 70506 7 50 7,0–50, 158,17 15817 158 17 17614242 1424 17,6–1424, respectivamente, respectivamente , respectivamente) 0,0006 00006 0006 3,67 367 3 67 1779 1,7–7, 0,0009 00009 0009 17,68 1768 68 21536 153 2–153, 58,9% 589 58 33/56 3356 33 56 00069 0069 0,006 78,6% 786 78 11/14 1114 11 14 0,0026. 00026 0,0026 0026 0,0026)] 0,0128 00128 0128 38,4 384 38 3,3–440,3, 334403 3,3–440,3 440 3,3–440,3) 0,0011 00011 0011 7,68 768 2,2–26,3. 22263 2,2–26,3 26 2,2–26,3) grave ruins (NMM 100 00 1.0 83,9 (83,9 92,9 (92,9 0,004 0004 004 [OR 12,0 120 [IC 1596 1,5–96 0,000 0000 4,8 48 IC9 2210 2,2–10 18, 7050 7,0–50 158,1 1581 15 1761424 142 17,6–1424 3,6 36 177 1,7–7 17,6 176 2153 2–153 58,9 33/5 335 006 0,00 78,6 11/1 111 0002 0,002 002 0,0026) 0,012 0012 012 38, 33440 3,3–440, 44 0,001 001 7,6 76 2226 2,2–26, 1. 83, (83, 92, (92, 12, 159 1,5–9 4, 221 2,2–1 705 7,0–5 158, 176142 17,6–142 3, 1,7– 17, 215 2–15 58, 33/ 0,0 78, 11/ 0,01 01 3344 3,3–440 7, 222 2,2–26 (83 (92 1,5– 22 2,2– 70 7,0– 17614 17,6–14 1,7 21 2–1 0, 334 3,3–44 2,2–2 (8 (9 1,5 2,2 7,0 1761 17,6–1 1, 2– 3,3–4 ( 2, 17,6– 3,3– 3,3

Abstract Objective Systemic lupus erythematosus (SLE) may cause irreversible organ damage. Pregnancy with SLE may have severe life-threatening risks. The present study aimed to determine the prevalence of severe maternal morbidity (SMM) in patients with SLE and analyze the parameters that contributed to cases of greater severity. Methods This is a cross-sectional retrospective study from analysis of data retrieved from medical records of pregnant women with SLE treated at a University Hospital in Brazil. The pregnant women were divided in a control group without complications, a group with potentially life-threatening conditions (PLTC), and a group with maternal near miss (MNM). Results The maternal near miss rate was 112.9 per 1,000 live births. The majority of PLTC (83.9%) and MNM (92.9%) cases had preterm deliveries with statistically significant increased risk compared with the control group (p = 0.0042; odds ratio [OR]: 12.05; 95% confidence interval [CI]: 1.5–96.6 for the MNM group and p = 0.0001; OR: 4.84; 95%CI: 2.2–10.8 for the PLTC group). Severe maternal morbidity increases the risk of longer hospitalization (p < 0.0001; OR: 18.8; 95%CI: 7.0–50.6 and p < 0.0001; OR: 158.17; 95%CI: 17.6–1424,2 for the PLTC and MNM groups, respectively), newborns with low birthweight (p = 0.0006; OR: 3.67; 95%CI: 1.7–7.9 and p = 0.0009; OR: 17.68; 95%CI: 2–153.6) for the PLTC and MNM groups, respectively] as well as renal diseases (PLTC [8.9%; 33/56; p = 0.0069] and MNM [78.6%; 11/14; p = 0.0026]). Maternal near miss cases presented increased risk for neonatal death (p = 0.0128; OR: 38.4; 95%CI: 3.3–440.3]), and stillbirth and miscarriage (p = 0.0011; OR: 7.68; 95%CI: 2.2–26.3]). Conclusion Systemic lupus erythematosus was significantly associated with severe maternal morbidity, longer hospitalizations, and increased risk of poor obstetric and neonatal outcomes. (SLE damage lifethreatening life threatening risks SMM (SMM severity crosssectional cross sectional Brazil complications PLTC, , (PLTC) MNM. . (MNM) 1129 112 9 112. 1000 1 000 1,00 births 83.9% 839 83 (83.9% 92.9% 929 92 (92.9% 0.0042 00042 0 0042 OR [OR] 12.05 1205 12 05 95 CI [CI] 15966 5 96 6 1.5–96. 0.0001 00001 0001 4.84 484 4 84 95%CI 95CI 22108 2 10 8 2.2–10. group. group) 18.8 188 18 70506 7 50 7.0–50. 158.17 15817 158 17 17614242 1424 17.6–1424, groups respectively, respectively respectively) 0.0006 00006 0006 3.67 367 3 67 1779 1.7–7. 0.0009 00009 0009 17.68 1768 68 2–153.6 21536 153 8.9% 89 [8.9% 33/56 3356 33 56 0.0069 00069 0069 78.6% 786 78 [78.6% 11/14 1114 11 14 0.0026. 00026 0.0026 0026 0.0026]) 0.0128 00128 0128 38.4 384 38 3.3–440.3, 334403 3.3–440.3 440 3.3–440.3]) 0.0011 00011 0011 7.68 768 2.2–26.3. 22263 2.2–26.3 26 2.2–26.3]) hospitalizations outcomes (MNM 100 00 1,0 83.9 (83.9 92.9 (92.9 0.004 0004 004 [OR 12.0 120 [CI 1596 1.5–96 0.000 0000 4.8 48 2210 2.2–10 18. 7050 7.0–50 158.1 1581 15 1761424 142 17.6–1424 3.6 36 177 1.7–7 17.6 176 2–153. 2153 8.9 [8.9 33/5 335 0.006 006 78.6 [78.6 11/1 111 0002 0.002 002 0.0026] 0.012 0012 012 38. 33440 3.3–440. 44 3.3–440.3] 0.001 001 7.6 76 2226 2.2–26. 2.2–26.3] 1, 83. (83. 92. (92. 0.00 12. 159 1.5–9 4. 221 2.2–1 705 7.0–5 158. 176142 17.6–142 3. 1.7– 17. 2–153 215 8. [8. 33/ 78. [78. 11/ 0.01 01 3344 3.3–440 7. 222 2.2–26 (83 (92 0.0 1.5– 22 2.2– 70 7.0– 17614 17.6–14 1.7 2–15 21 [8 [78 334 3.3–44 2.2–2 (8 (9 0. 1.5 2.2 7.0 1761 17.6–1 1. 2–1 [ [7 3.3–4 ( 2. 17.6– 2– 3.3– 3.3

Abstract Objective To evaluate the efficacy of immunotherapy for GTN treatment after methotrexate-resistance or in cases of multiresistant disease, through a systematic review, as well as to present the first 4 Brazilian cases of immunotherapy for GTN treatment. Methods Three independent researchers searched five electronic databases (EMBASE, LILACS, Medline, CENTRAL and Web of Science), for relevant articles up to February/2023 (PROSPERO CRD42023401453). The quality assessment was performed using the Newcastle Ottawa scale for case series and case reports. The primary outcome of this study was the occurrence of complete remission. The presentation of the case reports was approved by the Institutional Review Board. Results Of the 4 cases presented, the first was a low-risk GTN with methotrexate resistance unsuccessfully treated with avelumab, which achieved remission with sequential multiagent chemotherapy. The remaining 3 cases were high-risk multiagent-resistant GTN that were successfully treated with pembrolizumab, among which there were two subsequent gestations, one of them with normal pregnancy and healthy conceptus. Regarding the systematic review, 12 studies were included, only one of them on avelumab, showing a 46.7% complete remission rate. The remaining 11 studies were on pembrolizumab, showing an 86.7% complete remission rate, regardless of tumor histology. Both immunotherapies showed good tolerability, with two healthy pregnancies being recorded: one after avelumb and another after pembrolizumab. Conclusion Immunotherapy showed effectiveness for GTN treatment and may be especially useful in cases of high-risk disease, where pembrolizumab achieves a high therapeutic response, regardless of the histological type, and despite prior chemoresistance to multiple lines of treatment. methotrexateresistance disease review EMBASE, EMBASE (EMBASE LILACS Medline Science, Science , Science) February2023 February 2023 February/202 PROSPERO CRD42023401453. CRD42023401453 CRD . CRD42023401453) Board presented lowrisk low risk avelumab chemotherapy highrisk multiagentresistant resistant gestations conceptus 1 included 467 46 7 46.7 rate 867 86 86.7 histology tolerability recorded response type February202 202 February/20 CRD4202340145 46. 8 86. February20 20 February/2 CRD420234014 February2 2 February/ CRD42023401 CRD4202340 CRD420234 CRD42023 CRD4202 CRD420 CRD42 CRD4

Resumo Mola hidatiforme completa (MHC) é um tipo raro de gravidez, na qual 15 a 20% dos casos podem desenvolver neoplasia trofoblástica gestacional (NTG). O diagnóstico de NTG deve ser feito o mais cedo possível, pelo monitoramento semanal do hCG sérico após esvaziamento uterino. Relatamos o caso de uma paciente primigesta, de 23 anos de idade, com MHC, sem vigilância de hCG após esvaziamento uterino. Dois meses depois, a paciente compareceu na emergência com sangramento vaginal, sendo encaminhada ao Centro de Doenças Trofoblásticas do Hospital São Paulo, onde foi diagnosticada com NTG de alto risco, estádio e score de risco III:7 de acordo com a The International Federation of Gynecology and Obstetrics/Organização Mundial de Saúde (FIGO/OMS). O exame ultrassonográfico revelou útero aumentado com uma massa heterogênea constituída pormúltiplos vasos volumosos invadindo e desestruturando o miométrio. A paciente evoluiu com piora progressiva do sangramento vaginal após quimioterapia com o regime etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine (EMA-CO). Ela foi submetida a transfusão de sangue e embolização das artérias uterinas devido aos episódios graves de hemorragia vaginal, com completo controle do sangramento. O hCG atingiu valor negativo após o terceiro ciclo, havendo regressão completa da vascularização uterina anômala, assim como recuperação da anatomia uterina. O tratamento em um centro de referência permitiu o manejo adequado, principalmente no que se refere à embolização das artérias uterinas através da punção percutânea da artéria femoral, que foi crucial para evitar a histerectomia, permitindo a cura da NTG e a manutenção da vida reprodutiva.

Abstract Complete hydatidiform mole (CHM) is a rare type of pregnancy, in which 15 to 20% of the cases may develop into gestational trophoblastic neoplasia (GTN). The diagnostic of GTN must be done as early as possible through weekly surveillance of serum hCG after uterine evacuation.We report the case of 23-year-old primigravida, with CHM but without surveillance of hCG after uterine evacuation. Two months later, the patient presented to the emergency with vaginal bleeding and was referred to the Centro de Doenças Trofoblásticas do Hospital São Paulo. She was diagnosed with high risk GTN stage/score III:7 as per The International Federation of Gynecology and Obstetrics/World Health Organization (FIGO/WHO). The sonographic examination revealed enlarged uterus with a heterogeneous mass constituted of multiple large vessels invading and causing disarrangement of the myometrium. The patient evolved with progressive worsening of vaginal bleeding after chemotherapy with etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine (EMA-CO) regimen. She underwent blood transfusion and embolization of uterine arteries due to severe vaginal hemorrhage episodes, with complete control of bleeding. The hCG reached a negative value after the third cycle, and there was a complete regression of the anomalous vascularization of the uterus as well as full recovery of the uterine anatomy. The treatment in a reference center was essential for the appropriate management, especially regarding the uterine arteries embolization trough percutaneous femoral

OBJECTIVES: This study aimed to determine the effects of age, race/ethnicity, body mass index, and contraception on human chorionic gonadotropin (hCG) regression following the evacuation of a molar pregnancy. METHODS: This was a retrospective cohort study of 277 patients with molar pregnancies between January 1, 1994 and December 31, 2015. The rate of hCG regression was estimated using mixed-effects linear regression models on daily log-transformed serum hCG levels after evacuation. RESULTS: There were no differences in hCG half-lives among age (p=0.13) or race/ethnicity (p=0.16) groups. Women with obesity and hormonal contraceptive use demonstrated faster hCG regression than their counterparts (3.2 versus. 3.7 days, p=0.02 and 3.4 versus. 4.0 days, p=0.002, respectively). CONCLUSION: Age and race/ethnicity were not associated with hCG regression rates. Hormonal contraceptive use and obesity were associated with shorter hCG half-lives, but with unlikely clinical significance. It is important to understand whether the clinical characteristics of patients may influence the hCG regression curve, as it has been proposed as a way to predict the risk of gestational trophoblastic neoplasia.

Resumo Esse relato apresenta um caso de neoplasia trofoblástica gestacional após mola hidatiforme parcial ocorrida na tuba uterina. Trata-se de uma associação rara, cuja incidência estima-se de 1 em cada 20.000 a 100.000 gestações, havendomenos de 300 casos apresentados na literatura ocidental. O tema é importante porque apresenta critérios diagnósticos atuais para essa ocorrência incomum, que vinha sendo diagnosticada equivocadamente, não apenas sob o ponto de vista morfológico, como também imunohistoquímico. Da mesma forma, alerta o obstetra para a ocorrência da gravidez molar ectópica, que tende a evoluir com rotura tubária mais frequentemente do que os casos de gravidez ectópica não molar. Por fim, a evolução do caso para neoplasia trofoblástica gestacional impõe às pacientes com gravidez ectópica molar a necessidade de seguimento pós-molar tão rigoroso quanto nos casos de mola hidatiforme intrauterina, ainda que o tratamento quimioterápico determine elevadas taxas de cura.

Abstract This report presents the case of a patient with gestational trophoblastic neoplasia after a partial hydatidiform mole formed in the Fallopian tube. Ectopic molar pregnancy is a rare condition, with an estimated incidence of 1 in every 20,000 to 100,000 pregnancies; less than 300 cases of it have been reported in the Western literature. The present report is important because it presents current diagnostic criteria for this rare condition, which has been incorrectly diagnosed in the past, not only morphologically but also immunohistochemically. It also draws the attention of obstetricians to the occurrence of ectopic molar pregnancy, which tends to progress to Fallopian tube rupture more often than in cases of ectopic non-molar pregnancy. Progression to gestational trophoblastic neoplasia ensures that patients with ectopic molar pregnancy must undergo postmolar monitoring, which must be just as thorough as that of patients with intrauterine hydatidiform moles, even if chemotherapy results in high cure rates.

RESUMO Doença trofoblástica gestacional inclui um grupo interrelacionado de doenças originadas do tecido placentário, com tendências distintas de invasão local e metástase. A alta sensibilidade das dosagens seriadas de gonadotrofina coriônica humana aliada aos avanços do tratamento quimioterápico tornou a neoplasia trofoblástica gestacional, curável, na maioria das vezes, através da quimioterapia. No entanto, a cirurgia permanece ainda, da maior importância na condução de pacientes com doença trofoblástica gestacional, melhorando seu prognóstico. A cirurgia é necessária no controle de complicações da doença, tais como hemorragia, e em casos de neoplasia resistente/recidivada. Esta revisão discute as indicações e o papel das intervenções cirúrgicas durante o manejo de mulheres com gravidez molar e neoplasia trofoblástica gestacional.

ABSTRACT The Gestational Trophoblastic Disease includes an interrelated group of diseases originating from placental tissue, with distinct behaviors concerning local invasion and metastasis. The high sensitivity of the serial dosages of human chorionic gonadotrophin, combined with advances in chemotherapy treatment, have made gestational trophoblastic neoplasia curable, most often through chemotherapy. However, surgery remains of major importance in the management of patients with gestational trophoblastic disease, improving their prognosis. Surgery is necessary in the control of the disease's complications, such as hemorrhage, and in cases of resistant/relapsed neoplasia. This review discusses the indications and the role of surgical interventions in the management of women with molar pregnancy and gestational trophoblastic neoplasia.

OBJETIVO: Estimar a prevalência de histórico de violência sexual entre mulheres gestantes e sua associação com a percepção de saúde. MÉTODOS: Estudo transversal, com 179 mulheres maiores de 14 anos e grávidas de 14 a 28 semanas, entrevistadas em serviços públicos de saúde em São Paulo, SP, entre os anos de 2006 e 2007. Os instrumentos utilizados foram: inventário de violência sexual, inventário de dados sociodemográficos e questionário de qualidade de vida relacionada à saúde: "Medical Outcomes 12-Item Short-Form Health Survey" (SF-12®). Mulheres com e sem história de violência sexual foram comparadas quanto à idade, escolaridade, ocupação, estado civil, cor da pele e autopercepção de saúde física e mental. A violência sexual foi caracterizada em penetrativa ou não penetrativa. RESULTADOS: Houve prevalência de 39,1% de violência sexual entre as entrevistadas, sendo 20% do tipo penetrativo, cometida sobretudo por agressores conhecidos. Em 57% das mulheres a primeira agressão ocorreu antes dos 14 anos. Não houve diferenças sociodemográficas entre mulheres que sofreram e as que não sofreram violência sexual. Escores médios de percepção de saúde física entre as entrevistadas com antecedente de violência sexual foram menores (42,2; DP=8,3) do que das mulheres sem este antecedente (51,0; DP=7,5) (p<0,001). A percepção de saúde mental teve escore médio de 37,4 (DP=11,2) e 48,1 (DP=10,2) (p<0,001), respectivamente para os dois grupos. CONCLUSÕES: Houve alta prevalência de violência sexual entre as grávidas dos serviços de saúde avaliados. Mulheres com antecedente de violência sexual apresentaram pior percepção de saúde do que as sem esse antecedente.

OBJECTIVE: To estimate the prevalence of sexual violence history among pregnant women and its association with the self-perception of health status. METHODS: Cross-sectional study including a total of 179 pregnant women older than 14 years old at gestation week 14 to 28 attending public health services in the city of São Paulo, Southeastern Brazil, between 2006 and 2007. Data collection instruments included: questionnaire on sexual violence; questionnaire on sociodemographic data; and an assessment of health-related quality of life using the Medical Outcomes Study 12-Item Short-Form Health Survey (SF-12®). Age, skin color, education, occupational and marital status, and self-perception of physical and mental health were compared between women with and without a lifetime history of sexual violence. Sexual violence was categorized as penetrative and non-penetrative sex. RESULTS: Among all women interviewed, the prevalence of sexual violence was 39.1%, of which 20% were of penetrative type by known perpetrators. In 57% of cases, the first episode of violence was before the age of 14. There were no sociodemographic differences between women with and without history of sexual violence. Mean scores of self-perception of physical health among women with history of sexual violence were lower (42.2; SD= 8.3) compared to those without history of sexual violence (51.0; SD= 7.5) (p<0.001). Mean scores of self-perception of mental health were 37.4 (SD= 11.2) and 48.1 (SD= 10.2) (p<0.001), respectively. CONCLUSIONS: There was found high prevalence of sexual violence among pregnant women studied. Women with history of sexual violence showed poorer self-perception of health status compared to those without history of sexual violence.

OBJETIVO: Estimar la prevalencia de histórico de violencia sexual entre mujeres gestantes y su asociación con la percepción de salud. MÉTODOS: Estudio transversal, con 179 mujeres mayores de 14 años y embarazadas de 14 a 28 semanas, entrevistadas en servicios públicos de salud en Sao Paulo, Sureste de Brasil, entre los años de 2006 y 2007. Los instrumentos utilizados fueron: inventario de violencia sexual, inventario de datos sociodemográficos y cuestionario de calidad de vida relacionada con la salud: "Medical Outcomes 12-Item Short-Form Health Survey" (SF-12 ®). Mujeres con y sin historia de violencia sexual fueron comparadas con respecto a la edad, escolaridad, ocupación, estado civil, color de la piel y autopercepción de salud física y mental. La violencia sexual fue caracterizada en penetrativa o no penetrativa. RESULTADOS: Hubo prevalencia de 39,1% de violencia sexual entre las entrevistadas, siendo 20% del tipo penetrativo, cometida sobretodo por agresores conocidos. En 57% de las mujeres la primera agresión ocurrió antes de los 14 años. No hubo diferencias sociodemográficas entre mujeres que sufrieron y las que no sufrieron violencia sexual. Escores promedios de percepción de salud física entre las entrevistadas con antecedente de violencia sexual fueron menores (42,2; DP=8,3) con relación a las mujeres sin este antecedente (51,0; DP=7,5) (p<0,001). La percepción de salud mental tuvo escores promedio de 37,4 (DP= 11,2) y 48,1 (DP=10,2) (p<0,001), respectivamente para los dos grupos. CONCLUSIONES: Hubo alta prevalencia de violencia sexual entre las embarazadas de los servicios de salud evaluados. Mujeres con antecedente de violencia sexual presentaron peor percepción de salud con relación a las que no presentaban ese antecedente.

OBJETIVO: Estimar a prevalência de histórico de violência sexual entre mulheres gestantes e sua associação com a percepção de saúde. MÉTODOS: Estudo transversal, com 179 mulheres maiores de 14 anos e grávidas de 14 a 28 semanas, entrevistadas em serviços públicos de saúde em São Paulo, SP, entre os anos de 2006 e 2007. Os instrumentos utilizados foram: inventário de violência sexual, inventário de dados sociodemográficos e questionário de qualidade de vida relacionada à saúde: "Medical Outcomes 12-Item Short-Form Health Survey" (SF-12®). Mulheres com e sem história de violência sexual foram comparadas quanto à idade, escolaridade, ocupação, estado civil, cor da pele e autopercepção de saúde física e mental. A violência sexual foi caracterizada em penetrativa ou não penetrativa. RESULTADOS: Houve prevalência de 39,1% de violência sexual entre as entrevistadas, sendo 20% do tipo penetrativo, cometida sobretudo por agressores conhecidos. Em 57% das mulheres a primeira agressão ocorreu antes dos 14 anos. Não houve diferenças sociodemográficas entre mulheres que sofreram e as que não sofreram violência sexual. Escores médios de percepção de saúde física entre as entrevistadas com antecedente de violência sexual foram menores (42,2; DP=8,3) do que das mulheres sem este antecedente (51,0; DP=7,5) (p<0,001). A percepção de saúde mental teve escore médio de 37,4 (DP=11,2) e 48,1 (DP=10,2) (p<0,001), respectivamente para os dois grupos. CONCLUSÕES: Houve alta prevalência de violência sexual entre as grávidas dos serviços de saúde avaliados. Mulheres com antecedente de violência sexual apresentaram pior percepção de saúde do que as sem esse antecedente.

OBJECTIVE: To estimate the prevalence of sexual violence history among pregnant women and its association with the self-perception of health status. METHODS: Cross-sectional study including a total of 179 pregnant women older than 14 years old at gestation week 14 to 28 attending public health services in the city of São Paulo, Southeastern Brazil, between 2006 and 2007. Data collection instruments included: questionnaire on sexual violence; questionnaire on sociodemographic data; and an assessment of health-related quality of life using the Medical Outcomes Study 12-Item Short-Form Health Survey (SF-12®). Age, skin color, education, occupational and marital status, and self-perception of physical and mental health were compared between women with and without a lifetime history of sexual violence. Sexual violence was categorized as penetrative and non-penetrative sex. RESULTS: Among all women interviewed, the prevalence of sexual violence was 39.1%, of which 20% were of penetrative type by known perpetrators. In 57% of cases, the first episode of violence was before the age of 14. There were no sociodemographic differences between women with and without history of sexual violence. Mean scores of self-perception of physical health among women with history of sexual violence were lower (42.2; SD= 8.3) compared to those without history of sexual violence (51.0; SD= 7.5) (p<0.001). Mean scores of self-perception of mental health were 37.4 (SD= 11.2) and 48.1 (SD= 10.2) (p<0.001), respectively. CONCLUSIONS: There was found high prevalence of sexual violence among pregnant women studied. Women with history of sexual violence showed poorer self-perception of health status compared to those without history of sexual violence.

OBJETIVO: Estimar la prevalencia de histórico de violencia sexual entre mujeres gestantes y su asociación con la percepción de salud. MÉTODOS: Estudio transversal, con 179 mujeres mayores de 14 años y embarazadas de 14 a 28 semanas, entrevistadas en servicios públicos de salud en Sao Paulo, Sureste de Brasil, entre los años de 2006 y 2007. Los instrumentos utilizados fueron: inventario de violencia sexual, inventario de datos sociodemográficos y cuestionario de calidad de vida relacionada con la salud: "Medical Outcomes 12-Item Short-Form Health Survey" (SF-12 ®). Mujeres con y sin historia de violencia sexual fueron comparadas con respecto a la edad, escolaridad, ocupación, estado civil, color de la piel y autopercepción de salud física y mental. La violencia sexual fue caracterizada en penetrativa o no penetrativa. RESULTADOS: Hubo prevalencia de 39,1% de violencia sexual entre las entrevistadas, siendo 20% del tipo penetrativo, cometida sobretodo por agresores conocidos. En 57% de las mujeres la primera agresión ocurrió antes de los 14 años. No hubo diferencias sociodemográficas entre mujeres que sufrieron y las que no sufrieron violencia sexual. Escores promedios de percepción de salud física entre las entrevistadas con antecedente de violencia sexual fueron menores (42,2; DP=8,3) con relación a las mujeres sin este antecedente (51,0; DP=7,5) (p<0,001). La percepción de salud mental tuvo escores promedio de 37,4 (DP= 11,2) y 48,1 (DP=10,2) (p<0,001), respectivamente para los dos grupos. CONCLUSIONES: Hubo alta prevalencia de violencia sexual entre las embarazadas de los servicios de salud evaluados. Mujeres con antecedente de violencia sexual presentaron peor percepción de salud con relación a las que no presentaban ese antecedente.